Clinical Trial Update: A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase II trial evaluating ZKY001 Eye Drops for corneal epithelial defect, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Epithelial Defect

Drugs mentioned

• ZKY001 Eye Drops

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Corneal Epithelium Defect | Phase 2 | Status: COMPLETED